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Migration and psychosis: our smoking lung?  
 
To read the history of humankind is to read a history of migration. From the first human 
exoduses out of Africa, to Greek and Roman empires which sought territorial expansion, to the 
Ming dynasty’s pioneering voyages of exploration, to the flight of ethnic, religious, political and 
sexual minorities escaping persecution from various authoritarian regimes or internal conflicts, to 
the economic migrants from continental Europe, Asia, the Middle East, and South and Central 
America who sought better lives for themselves and their families on new continents, migration 
is arguably the defining feature of a singular human experience that binds our past, present and 
future. The drivers and consequences of migration also leave indelible marks on the history of 
humankind. In equal measure, they result in leaps forward for civilization – enriching cultural, 
social, genetic and economic diversity and human development – and pockmarks which serve to 
remind us of the seemingly ceaseless bounds of human savagery and brutality. 
To a psychiatric epidemiologist, migration is arguably associated with one of the public health 
inequalities of the last 100 years: that certain migrants, their children, and their children’s children 
are as much as 10 times more likely to meet diagnostic criteria for psychotic disorder than the 
majority (usually white Caucasian) population in a given setting1. The exact magnitude of this risk 
varies, depending on the given migrant group and setting in which the study is conducted. In the 
UK, for example, psychosis risk ranges from slight increases (of 1.5 or less) for white migrants, to 
2-4 times greater risk for people of Pakistani and Bangladeshi origin, and up to 10 times higher 
rates amongst black Caribbean and African groups2. Elsewhere, elevated risk also follows historical 
migration flows, such as amongst the Surinamese and Moroccan populations in the Netherlands1, 
or East African migrants to Sweden3. Emerging research from countries which have experienced 
unprecedented contemporary immigration pressures4 also shows that incidence rates are 
elevated amongst migrant groups.  
It is only right that this epidemiological literature is subject to proper scrutiny to determine 
whether these patterns are causal. If they are not, then the alternatives are no less palatable: that 
other social or economic exposures are so entrenched within certain black and ethnic minority 
(BME) sections of society that they are powerful enough to increase the chance of experiencing a 
psychotic disorder by up to 1000%; or that the tools, practitioners and institutions tasked with 
making reliable and valid diagnostic assessments are so unfit for purpose, or so grossly inept at 
differentiating between normal cultural mores of behaviour and psychotic symptoms, that for 
every one migrant correctly diagnosed, a further nine may be misdiagnosed with psychotic 
disorder.  
Scrutiny of the evidence in relation to misdiagnosis does not strongly support this as an 
explanation of higher rates. There may be poor inter-rater reliability between psychiatrists in 
agreeing on a specific psychotic diagnosis, but this does not appear to be racially biased5. Further, 
few modern epidemiological studies rely solely on clinician-rated diagnoses to measure 
outcomes, instead using carefully operationalized criteria to reach standardized diagnoses2,6. 
Finally, in the UK and elsewhere, the ethnic composition within clinical psychiatry is increasingly 
diverse, far from the monochromatic contrast that implicitly surrounds the misdiagnosis debate. 
In a recent study, for example, which also found elevated rates of psychotic disorder in BME 
groups in rural England6, operationalized diagnoses were made by a panel of psychiatrists from 
over 13 different ethnic backgrounds.  
Further new empirical data offer important directions. For example, raised rates do not seem 
to be entirely attributable to differences between BME groups and the majority population in 
socioeconomic status7. Other recent research, from Sweden, has demonstrated that refugee 
migrants are at considerably elevated risk of non-affective psychotic disorders compared with 
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both the Swedish-born population and, importantly, other migrants from the same regions of 
origin3. The implication is that severe exposure to pre-migratory adversities, including war, famine 
and persecution, or the hazards involved in the transitory process of migration itself, may be 
aetiologically relevant to psychosis risk. Additional studies suggest that exposure to other severely 
traumatic migration-related experiences, such as exposure to genocide7, also increases 
schizophrenia risk. Nonetheless, these data would not explain why elevated rates of psychotic 
disorder persist in successive generations following the index immigration event. Other factors 
must be relevant, possibly including experiences of racism and discrimination, although further 
research is needed on this issue. 
We now require an integration of observational data with sociological, ethnographic, 
experimental psychology and neuroscience research to shed light on the possible pre-, peri- and 
post-migratory factors that increase psychosis risk amongst BME groups. A recent study from 
social neuroscience, for example, suggests that healthy volunteers from second generation 
migrant backgrounds exhibit elevated neural responses to stress following a sociocultural 
challenge8. If we can further elucidate the mechanisms through which such stressors may lead to 
psychosis – potentially encompassing complex interactions between genetic, biological and social 
factors – this will not only move us closer to understanding the excess risks among BME 
communities, but in society at large. Aside from psychosis (and, perhaps, post-traumatic stress 
disorder), there is less consistent evidence that migrants are at higher risk of other mental health 
conditions; this specificity would be one of several important criteria helping to establish 
causation. 
Further studies are also required in settings where the increased psychosis risk amongst 
migrants is not observed. Several examples exist, including the absence of raised rates in people 
of Indian descent in the UK2, Turkish descent in the Netherlands1, or Hispanic origin in the US9. 
Canada is another putative counterfactual setting, given both its foundation on a relatively recent 
migration history, and the effects on mental health of indigenous First Nations people in this 
context.  
Studies in settings where white migrants form the minority group would also shed further 
light on the role of migration in psychosis risk. South Africa provides a possible example. 
Nonetheless, while white migrants in this context would be the minority in terms of population 
size, they also continue to hold a disproportionate balance of socioeconomic capital, which may 
negate any effect; in either case, the aetiological implications would be illuminating. For various 
reasons, and not without considerable challenges, Brazil, China, Japan and Zimbabwe present 
other settings for such counterfactual study.  
Using data from the UK, we found that, if we could identify the drivers of the elevated 
psychosis risk in BME groups, we could prevent up to 22% of new cases of first episode psychosis 
in the general population, and up to two thirds in BME groups specifically10. This major health 
inequality may be to psychiatry what nicotine exposure was to bronchogenic carcinomas over 65 
years ago11: our smoking lung. The psychiatric research community has an unparalleled duty to 
advance our aetiological understanding on this issue in order to eradicate this gross social 
injustice.  
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